Navigation Links
Student, 16, invents new drug cocktail to fight cystic fibrosis, wins Canadian biotech challenge
Date:5/10/2011

While many 16-year-olds are content with PlayStation, Toronto-area student Marshall Zhang used the Canadian SCINET supercomputing network to invent a new drug cocktail which could one day help treat cystic fibrosis.

The Grade 11 student at Bayview Secondary School in Richmond Hill so impressed eight eminent scientists at the National Research Council of Canada laboratories in Ottawa they awarded him first prize today in the 2011 Sanofi-Aventis BioTalent Challenge.

Jonathan Khouzam, Simon Leclerc, Francis Marcogliese, all 19, of Montreal's CGEP Collge Jean-de-Brbeuf, won the 2nd place prize for finding a way to produce a great sorbet without geletin, potentially opening a large new vegetarian market for the popular frozen dessert. Geletin is derived from the skin and bones of animals.

First and second place winners receive $5,000 and $4,000 respectively. The trio from Montreal also won a special $1,000 prize for the project deemed by the judges to have the greatest commercial potential.

Marshall and the Montreal team will compete against US and Australian teams at the International BioGENEius Challenge in Washington, DC, June 27, held in conjunction with the Biotechnology Industry Organization's (BIO) Annual International Convention.

The other top prizes were collected by:

  • 3rd place ($3,000): Shannon Watson, 18, a Grade 12 student at Ottawa's Cantebury High School, who identified bacteria in a pro-biotic fermented milk product from Zambia that inhibit the growth of antibiotic-resistant bacteria;

  • 4th place ($2,000): Yasamin Mahjoub, 16, a Grade 11 student at Sir Winston Churchill High School, Calgary, who showed that hormones produced by pregnant women protect neurons from the effects of iron accumulation in the brain, suggesting a new line of inquiry into the causes and treatment of multiple sclerosis; and

  • 5th place ($1,000): Siyuan Cheng, 14, a Grade 9 student at
    '/>"/>

Contact: Terry Collins
tc@tca.tc
416-538-8712
Bioscience Education Canada
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. University of Nevada, Reno invents next-gen device to track worlds air quality
2. NJIT licensee invents industrial process for grinding cement and other cementitious materials
3. Purdue researcher invents molecule that stops SARS
4. Host change alters toxic cocktail
5. MicroRNA cocktail helps turn skin cells into stem cells
6. Chemical cocktail affects humans and the environment
7. Plasma produces KO cocktail for MRSA
8. Powerful nutrient cocktail can put kids with Crohns into remission
9. Skip this cocktail party
10. Parsley, celery carry crucial component for fight against breast cancer, MU researcher finds
11. Hitting target in cancer fight now easier with new nanoparticle platform, UCLA scientists say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market Intelligence,s ... The Convergence of Commerce and Privacy" forecasts that ... biometric apps will be downloaded to smart mobile ... mobile biometrics market is projected to generate more ... during the seven-year forecast period.    ...
(Date:7/13/2015)... OXFORD, Conn. , Jul. 13, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/188684 for ... NXT-ID achieves another new convenient and secure method ... expands new, innovative payment methods, introduced with its ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... major study sheds new light on the role of carbon ... indicates that instead of sinking, carbon dioxide is often consumed ... a dimly lit area 100 to 1,000 meters below the ... where it can be stored and prevented from re-entering the ...
... from preterm birth are staggering. In Canada, outlays for ... be almost $2 billion per year. In a 5-year, ... to mothers who had entered premature labor led to ... the study are reported in the January issue of ...
... New predictions about bird flu, involving the use of ... antiviral drugs might be the best way to deal ... has not triggered a worldwide human epidemic yet because ... this ability, it would take 6-8 months to develop ...
Cached Biology News:Ocean's 'twilight zone' may be a key to understanding climate change 2
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... the Company,s Chief Financial Officer has resigned.  The Company ... Financial Officer who retired in December 2014, as full ... a permanent successor.     Andy Ashworth ... and ensure a smooth transition.  Andy was the Company,s ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
(Date:7/29/2015)... , July 29, 2015  Pfenex Inc. (NYSE MKT: ... results will be released on Thursday, August 13, 2015, ... Time, Pfenex management will host a conference call to ... A press release outlining the financial results and business ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris ... announced it has selected an optimized Erk inhibitor ... in the development of a new class of ... pathway represents a prime target for therapeutic intervention ... activities and survival benefits for B-Raf and Mek ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... Wisconsin's research and development funding has exceeded expectations, reaching $3.6 billion ... a target of $3.3 billion by 2005. , ,In 2002, ... per capita, and 13 th in academic R&D spending. ... growth rate in R&D the last few years," said David Ward, ...
... at Chippewa Valley Technical College in Eau Claire are ... micro-level surface analysis to firms or organizations with an ... says three students will comprise each of five teams ... believes that firms considering the purchase of an electron ...
... Wireless Facilities, Inc. , a global ... communication networks, technology networks and security systems, announced today ... and deployment services for the City of Madison, Wisconsin's ... company Cellnet, and in coordination with Madison Gas & ...
Cached Biology Technology:New report says Wisconsin R&D spending exceeding expectations 2
... HEEBO (Human Exonic Evidence Based Oligonucleotide) Genome ... Oligonucleotide ) Genome Set contain a collection ... from constitutively expressed exons, allowing interrogation of ... leading researchers at Stanford University and UCSF, ...
Rabbit polyclonal to XPC ( Abpromise for all tested applications). Antigen: Synthetic peptide from N-terminus of Human XPC conjugated to a carrier protein Entrez Gene ID: 7508 Swiss ...
Rabbit polyclonal to NIRF ( Abpromise for all tested applications). Antigen: Synthetic peptide derived from residues 186-235 of human NIRF. Entrez Gene ID: 115426 Swiss Protein ID: Q96PU...
...
Biology Products: